Shanghai Fosun Pharmaceutical's subsidiary has had its drug registration application for Decitabine accepted by the National Medical Products Administration for review.

18:25 08/01/2026

Fosun Pharma (02196) announced that its subsidiary, Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd., has recently submitted a new drug registration application for the capsule of the drug Fruquintinib Dicarboxylate (project code: SAF-189, application for registration classification: chemical drug class 1) to the National Medical Products Administration for review. The indication for this application is for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients with anaplastic lymphoma kinase (ALK) positive.

Shanghai Fosun Pharmaceutical (02196) announced that its subsidiary, Fosun Pharma (Group) Co., Ltd. (hereinafter referred to as "the Company"), has had its drug registration application for the product known as Du Ruxolitinib Capsules (project code: SAF-189, application registration classification: Class 1 chemical drugs; hereinafter referred to as "the new drug") accepted by the National Medical Products Administration. The indication for this application is for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) patients who are positive for anaplastic lymphoma kinase (ALK).

HK Stock Market Move | CHUANGXIN IND(02788) increased by more than 7% in the afternoon, the substitution of aluminum for copper is expected to accelerate, the company is expanding its electrolytic aluminum production capacity in Saudi Arabia.

Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.

Soochow Securities maintains a "outperform" rating on Walmart Inc. (WMT.US), but removes it from the list of preferred stocks.

Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.

Soochow Securities maintains a "outperform" rating on Walmart Inc. (WMT.US), but removes it from the list of preferred stocks.